|Anti-FYa||BGFYA002||1 x 2ml|
The FYa and FYb antigens were reported in 1950 and 1951 respectively. Anti-FYa has been implemented in immediate and delayed Haemolytic Transfusion reactions and Haemolytic Disease in the new born. Indirect agglutination of red cells that carry the FYa – antigen occurs in the antiglobulin phase. In the absence of the FYa– antigen, no indirect agglutination is generally observed.
The Biorex Diagnostics Anti-FYa reagent consists of human monoclonal antibodies diluted in phosphate buffer containing sodium chloride and bovine albumin. The reagent requires no further dilution or addition for recommended techniques.